Simtomax® at the UEG Week in Vienna
30 Oct 2014
The 22nd United European Gastroenterology week (UEGW) took place last week in Vienna, with 13’000 participants. Many different topics were covered in more than170 sessions, conferences, workshops or presentations. Simtomax® was particularly put in evidence in four poster sessions, a private conference and in the exhibition.
Abstracts and Poster presentations
Four abstracts were accepted for presentation, outlining the most recent conclusions drawn in various clinical studies with Simtomax®
- Point Of Care Testing For Adult Coeliac Disease: A Potential Role In Endoscopy, a study by Prof David Sanders at the Royal Hallamshire Hospital in Sheffield, (UK), investigating the potential use of point-of-care tests for Celiac Disease in pre-endoscopy
- Comparison Of Three Commercially Available Point Of Care Tests For Coeliac Disease, a study by Dr Peter Mooney at Royal Hallamshire Hospital in Sheffield, (UK)
- Assessing Adherence To Gluten Free Diet In Coeliac Disease: Can We Avoid Duodenal Biopsy?, another study by the same group at Royal Hallamshire Hospital in Sheffield, (UK)
- Efficacy Of Deamidated Gliadin Peptide-Based Point-Of-Care Test (Simtomax) For The Early Diagnosis Of Coeliac Disease In Paediatric Patients, a study by Dr Isabel Polanco from Chidren ́s University Hospital La Paz in Madrid (Spain)
Prof David Sanders presented the clinical data from his study performed on over 500 patients at the Royal Hallamshire Hospital in Sheffield, (UK), suggesting the potential use of Simtomax® in pre-endoscopy.
« Simtomax could be used to appropriately identify patients requiring a duodenal biopsy within the endoscopic setting. »
Dr Michela Schaeppi, from the Pediatric Gastroenterology Unit, Geneva University (Switzerland) presented the clinical study performed on 112 patients.
Simtomax® in the exhibition
Simtomax was present on the booth of our commercial partner Tillotts Pharma, where several visitors stopped by.